27 August 2020

HIPR winner of Vitalis Scholarship 2020

Home news
HIPR winner of Vitalis Scholarship 2020

Two prestigious awards, Vitalis Scholarship and eHealth Award, were at the center of Vitalis' first day.

The scholarship went to Måns Lööf, a nurse and digital care developer at Region Gävleborg, who developed the communication tool HIPR. It is used today in both BUP (child and youth psychiatry) and the region's adult psychiatric clinics.

- It has been a fantastic but also very tough journey, to take the idea off the floor and manage to get it into the daily business. Winning the Vitalis scholarship on top of that now is a wonderful confirmation, he says.

HIPR is based on an app, which is used by patients every day. Patients register if they have taken their medicine as well as pulse and blood pressure. The patients can also describe the effect of the medicine and any side effects. At the clinic, a nurse registers the patients' experiences and can communicate about the treatment via a secure messaging procedure. Efficiency has increased significantly since the app was launched two years ago: staff state that they can take care of up to 90 percent more patients per day - in addition with increased care quality.

- We have very many patients who are able to use the digital aids. It frees up time and allows us to put more energy on the group of patients who need more care, says Måns.

- For me, it is the biggest benefit: to have time to help these patients.

The scholarship, SEK 50,000, he wants to use to further develop the app.

- I want to make it even better. Of course, I also hope that more regions want to join to this way of working. I know there are other regions that are ready to go.

The scholarship jury's motivation states, among other things:
"A fantastic example of business-driven development that puts power and initiative in the patient's hands… HIPR has great potential in a number of diagnostic areas… For an innovation that has increased care quality, efficiency, patient participation and trust in treatment."

Download the pressrelease (in Swedish)